WILMINGTON, DE / ACCESSWIRE / March 28, 2023 / Transparency Market Research Inc. - The peripheral vasodilator drugs market size was valued at USD 6.0 Bn in 2022, and it is estimated to expand at a ...

Orlando, FL - Investigators for the Limbs International Medical Buflomedil (LIMB) trial group believe they have the first proof that buflomedil (Fonzylane®, Cephalon), a vasoactive agent, can reduce ...

Peripheral arterial disease, also known as peripheral vascular disease, is a condition in which arteries that carry blood to the legs (or less commonly the arms) are narrowed or blocked. The usual ...

Today, acute heart failure represents the most common reason for hospitalization in the over-65 population. Although hospital care improves symptoms in the first 24 hours after admission in around 50 ...

Please provide your email address to receive an email when new articles are posted on . Transdermal nitroglycerin and placebo had similar outcomes for hot flash ...

Fenoldopam mesylate, a benzazepine derivative, is the first selective dopamine-1–receptor agonist that has been approved for clinical use. Administered parenterally, it acts predominantly as a ...

The National Institute for Health and Care Excellence (NICE) has today issued final guidance recommending naftidrofuryl oxalate as an option for the treatment of people who have intermittent ...